BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9166984)

  • 1. Tissue repair and angiotensin II generated at sites of healing.
    Weber KT; Sun Y; Katwa LC; Cleutjens JP
    Basic Res Cardiol; 1997 Apr; 92(2):75-8. PubMed ID: 9166984
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue angiotensin II and myocardial infarction.
    Sun Y; Weber KT
    EXS; 1996; 76():479-88. PubMed ID: 8805813
    [No Abstract]   [Full Text] [Related]  

  • 3. Recruitable ACE and tissue repair in the infarcted heart.
    Weber KT; Sun Y
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):295-303. PubMed ID: 11967815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.
    Weber KT
    Circulation; 1997 Dec; 96(11):4065-82. PubMed ID: 9403633
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
    Pfeffer JM; Fischer TA; Pfeffer MA
    Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
    [No Abstract]   [Full Text] [Related]  

  • 6. Local angiotensin II and myocardial fibrosis.
    Sun Y
    Adv Exp Med Biol; 1997; 432():55-61. PubMed ID: 9433511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and the control of cardiovascular structure.
    Pratt RE
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S120-8. PubMed ID: 9892152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diversity in mechanism of angiotensin II production and application of the suppressive agents].
    Miyazaki T
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
    Jugdutt BI; Idikio H; Uwiera RR
    Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.
    Makino N; Hata T; Sugano M; Dixon IM; Yanaga T
    J Mol Cell Cardiol; 1996 Mar; 28(3):507-17. PubMed ID: 9011634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound healing following myocardial infarction.
    Weber KT; Sun Y; Katwa LC
    Clin Cardiol; 1996 Jun; 19(6):447-55. PubMed ID: 8790947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
    Sun Y; Zhang JQ; Zhang J; Ramires FJ
    J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors].
    Aronov DM
    Ter Arkh; 2000; 72(12):5-7. PubMed ID: 11201833
    [No Abstract]   [Full Text] [Related]  

  • 14. Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.
    Morgan K
    Br Heart J; 1994 Sep; 72(3 Suppl):S3-10. PubMed ID: 7946800
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II receptor binding following myocardial infarction in the rat.
    Sun Y; Weber KT
    Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
    J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological intervention in post-infarction wound healing.
    Jugdutt BI
    EXS; 1996; 76():501-12. PubMed ID: 8805815
    [No Abstract]   [Full Text] [Related]  

  • 18. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction.
    Yoshida K; Kohzuki M; Casley DJ; Johnston CI
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):357-65. PubMed ID: 9733347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.